D Dalkara

Summary

Publications

  1. doi Enhanced gene delivery to the neonatal retina through systemic administration of tyrosine-mutated AAV9
    D Dalkara
    Department of Chemical Engineering, The Helen Wills Neuroscience Institute, The University of California, Berkeley, CA 94720 3190, USA
    Gene Ther 19:176-81. 2012
  2. pmc Retinoschisin gene therapy in photoreceptors, Müller glia or all retinal cells in the Rs1h-/- mouse
    L C Byrne
    1 Department of Molecular and Cellular Biology, The Helen Wills Neuroscience Institute, The University of California, Berkeley, CA, USA 2 Department of Chemical and Biomolecular Engineering, The Helen Wills Neuroscience Institute, The University of California, Berkeley, CA, USA 3 Department of Bioengineering, The Helen Wills Neuroscience Institute, The University of California, Berkeley, CA, USA
    Gene Ther 21:585-92. 2014

Collaborators

  • D V Schaffer
  • L C Byrne
  • J G Flannery
  • T Lee
  • B E Oztürk
  • M Visel
  • C Fortuny

Detail Information

Publications2

  1. doi Enhanced gene delivery to the neonatal retina through systemic administration of tyrosine-mutated AAV9
    D Dalkara
    Department of Chemical Engineering, The Helen Wills Neuroscience Institute, The University of California, Berkeley, CA 94720 3190, USA
    Gene Ther 19:176-81. 2012
    ..This approach provides a new methodology for the development of retinal gene therapies or creation of animal models of neurodegenerative disease...
  2. pmc Retinoschisin gene therapy in photoreceptors, Müller glia or all retinal cells in the Rs1h-/- mouse
    L C Byrne
    1 Department of Molecular and Cellular Biology, The Helen Wills Neuroscience Institute, The University of California, Berkeley, CA, USA 2 Department of Chemical and Biomolecular Engineering, The Helen Wills Neuroscience Institute, The University of California, Berkeley, CA, USA 3 Department of Bioengineering, The Helen Wills Neuroscience Institute, The University of California, Berkeley, CA, USA
    Gene Ther 21:585-92. 2014
    ..These results collectively point to the importance of cell targeting and appropriate vector choice in the success of retinal gene therapies. ..